ZA885502B - Preparation for preventing or combating complications in diabetes - Google Patents

Preparation for preventing or combating complications in diabetes

Info

Publication number
ZA885502B
ZA885502B ZA885502A ZA885502A ZA885502B ZA 885502 B ZA885502 B ZA 885502B ZA 885502 A ZA885502 A ZA 885502A ZA 885502 A ZA885502 A ZA 885502A ZA 885502 B ZA885502 B ZA 885502B
Authority
ZA
South Africa
Prior art keywords
met
diabetes
preventing
preparation
combating
Prior art date
Application number
ZA885502A
Other languages
English (en)
Inventor
Robby Huisman
Huisman Robby
Original Assignee
Akzo Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nv filed Critical Akzo Nv
Publication of ZA885502B publication Critical patent/ZA885502B/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/33Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • A61K38/35Corticotropin [ACTH]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22Hormones
    • A61K38/28Insulins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Diabetes (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
ZA885502A 1987-08-14 1988-07-27 Preparation for preventing or combating complications in diabetes ZA885502B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NL8701912 1987-08-14

Publications (1)

Publication Number Publication Date
ZA885502B true ZA885502B (en) 1989-04-26

Family

ID=19850453

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA885502A ZA885502B (en) 1987-08-14 1988-07-27 Preparation for preventing or combating complications in diabetes

Country Status (9)

Country Link
EP (1) EP0303308B1 (xx)
JP (1) JPS6466129A (xx)
KR (1) KR890003403A (xx)
AT (1) ATE63821T1 (xx)
AU (1) AU612169B2 (xx)
DE (1) DE3863027D1 (xx)
DK (1) DK418788A (xx)
NZ (1) NZ225621A (xx)
ZA (1) ZA885502B (xx)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5212154A (en) * 1987-08-14 1993-05-18 Akzo N.V. Preparation for treating complications in diabetes
WO1993015752A1 (en) * 1992-02-17 1993-08-19 Akzo N.V. Anti-neuropathic composition
WO1993023072A1 (en) * 1992-05-13 1993-11-25 Akzo N.V. Aqueous hexapeptide compositions

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2789080A (en) * 1952-08-14 1957-04-16 Christensen Henry Marinus Insulin-albumin compositions
CH330318A (de) * 1953-09-08 1958-05-31 British Drug Houses Ltd Verfahren zur Herstellung eines Insulinpräparates mit verlängerter Wirkungszeit
NL175174C (nl) * 1972-03-31 1984-10-01 Akzo Nv Werkwijze ter bereiding van een farmaceutisch preparaat met psychofarmacologische werking, dat een peptide of peptide-derivaat als actief bestanddeel bevat, alsmede een werkwijze ter bereiding van deze peptiden.
CH650679A5 (de) * 1981-08-27 1985-08-15 Lilly Co Eli Gegen diabetes mellitus wirksames pharmazeutisches mittel.
CA1196863A (en) * 1983-06-08 1985-11-19 Mattheus F.A. Goosen Slow release injectable insulin composition
US4623715A (en) * 1984-10-22 1986-11-18 Hoechst Aktiengeselleschaft Novel peptides which are active on the central nervous system and have an action on the cholinergic system

Also Published As

Publication number Publication date
JPS6466129A (en) 1989-03-13
ATE63821T1 (de) 1991-06-15
KR890003403A (ko) 1989-04-14
DK418788A (da) 1989-02-15
DE3863027D1 (de) 1991-07-04
DK418788D0 (da) 1988-07-26
EP0303308B1 (en) 1991-05-29
AU612169B2 (en) 1991-07-04
NZ225621A (en) 1990-11-27
EP0303308A1 (en) 1989-02-15
AU2063388A (en) 1989-02-16

Similar Documents

Publication Publication Date Title
GR3007043T3 (xx)
AU3613089A (en) Amino acid derivatives
AU3079789A (en) Amino acid derivatives
AU7094487A (en) Novel amino acid derivatives
AU1261788A (en) Amino acid derivatives
ZA882347B (en) Amino acid derivatives
AU2330788A (en) Amino acid derivatives
ZA885502B (en) Preparation for preventing or combating complications in diabetes
AU599401B2 (en) Amino acid derivatives
AU3329289A (en) Amino acid derivatives
AU2298288A (en) Amino acid derivatives
AU3255589A (en) Amino acid derivatives
AU1630088A (en) Amino acid derivatives
GR3003930T3 (xx)
AU622734B2 (en) Amino acid derivatives
AU3119989A (en) Amino acid derivatives
EP0296227A4 (en) ADMINISTRATION OF AMINOACIDS BY NASAL ROUTE.
AU623631B2 (en) Amino acid derivatives
GB8707515D0 (en) Amino acid derivatives
IE880726L (en) Amino acid derivatives.
IE882973L (en) Amino acid derivatives.
IE881825L (en) Polyfluorinated amino acid derivatives
IE871528L (en) Amino acid derivatives
IE870512L (en) Amino acid derivatives
IE872080L (en) Amino acid derivatives